Get to grips with technologies and novel platforms for efficient upstream and downstream processes
Build a strategy for monitoring quality across your process with PAT and automated analytics
Simplify manufacturing automation and prepare for commercialization
Clinical and Early Stage CAR T Cell and Gene Therapy Advances
Transition technologies from bench to bedside: CRISPR, Exosomes and more.
Push the boundaries of CD19 with solid tumours, combination therapies and safety switches
Understand how to build a sustainable process early on for optimum clinical translation
Supply Chain Barriers: Upstream and Downstream Considerations
Stay up to date on cryo considerations when moving from clinical to commercial phase manufacturing
Improve confidence in your raw material supply chain - vectors, risk mitigation and more
Prepare for successful delivery to patients & supply chain scale up
Cell & Gene Therapy Commercialization
Optimise the way you work with external partners to drive commercialization
Work towards industry 4.0 - integrating manufacturing and delivery into healthcare
Ensure profitability with forward thinking in facility design and scalability strategies
Bio fabrication - The Path to Commercialization: With ARMI
Stay tuned for more updates soon
In collaboration with our event partners ARMI (Advanced Regenerative Manufacturing Institute) we will be bringing you an exciting day jam packed with content on making practical the large-scale manufacturing of engineered tissues and tissue-related technologies, to benefit existing industries and grow new ones
Cell and Gene Therapy Connect - Partnering Track
Tackle collaboration - new outsourcing models, when to make the decision to `spin out` and more
Keep abreast of the evolving landscape of cell and gene therapies
Dive into pharmacoeconomic approaches to reimbursement
Venue
Hynes Convention Center, 900 Boylston Street, Boston, Massachusetts, United States
